X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atrial fibrillation (14) 14
cardiac & cardiovascular systems (13) 13
stroke (11) 11
warfarin (11) 11
index medicus (9) 9
risk (7) 7
dabigatran (6) 6
thromboembolism (6) 6
abridged index medicus (5) 5
aged (5) 5
anticoagulants (5) 5
cardiac arrhythmia (5) 5
confidence intervals (5) 5
denmark - epidemiology (5) 5
female (5) 5
humans (5) 5
male (5) 5
therapy (5) 5
aged, 80 and over (4) 4
apixaban (4) 4
atrial fibrillation - epidemiology (4) 4
care and treatment (4) 4
cohort studies (4) 4
comorbidity (4) 4
fibrillation (4) 4
health risk assessment (4) 4
hypertension (4) 4
identification methods (4) 4
mortality (4) 4
patients (4) 4
stroke - epidemiology (4) 4
stroke prevention (4) 4
age (3) 3
analysis (3) 3
aspirin (3) 3
atrial fibrillation - drug therapy (3) 3
bleeding (3) 3
cardiovascular (3) 3
chronic kidney disease (3) 3
diabetes (3) 3
health aspects (3) 3
health risks (3) 3
internal medicine (3) 3
kidney diseases (3) 3
medical research (3) 3
medicine, experimental (3) 3
middle aged (3) 3
peripheral vascular disease (3) 3
population studies (3) 3
registries (3) 3
risk reduction (3) 3
rivaroxaban (3) 3
safety (3) 3
statistical analysis (3) 3
stroke - prevention & control (3) 3
time in therapeutic range (3) 3
vitamin k (3) 3
vitamin k antagonist (3) 3
warfarin - adverse effects (3) 3
warfarin - therapeutic use (3) 3
acute myocardial-infarction (2) 2
alcohol (2) 2
anticoagulants - administration & dosage (2) 2
anticoagulants - adverse effects (2) 2
anticoagulants - therapeutic use (2) 2
antiplatelet therapy (2) 2
arrhythmia (2) 2
cardiac patients (2) 2
cardiology (2) 2
cardiovascular agents (2) 2
chronic kidney failure (2) 2
chronic kidney-disease (2) 2
dabigatran - adverse effects (2) 2
drug therapy (2) 2
efficacy (2) 2
follow-up studies (2) 2
gda.55 dansk litteratur 1945-99 (2) 2
glomerular filtration rate (2) 2
glomerular-filtration-rate (2) 2
heart failure (2) 2
hematology (2) 2
hemodialysis-patients (2) 2
hemorrhage (2) 2
hospitalization (2) 2
hospitalization - statistics & numerical data (2) 2
infarction (2) 2
international normalized ratio (2) 2
intracranial hemorrhages - chemically induced (2) 2
liver diseases (2) 2
myocardial infarction (2) 2
noac (2) 2
normalized ratio control (2) 2
oral anticoagulant (2) 2
oral anticoagulants (2) 2
oral anticoagulation (2) 2
percutaneous coronary (2) 2
population (2) 2
prevention (2) 2
register (2) 2
regression analysis (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 64, Issue 23, pp. 2471 - 2482
Journal Article
Journal Article
European heart journal, ISSN 0195-668X, 04/2019
To investigate the risk of stroke/thromboembolism (TE) and major bleeding associated with anaemia among patients with atrial fibrillation (AF). Also, to assess... 
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 6, pp. 752 - 753
  Atrial fibrillation (AF) patients with creatinine clearance below 30 ml/min have been excluded from randomized controlled trials of non-vitamin K antagonist... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Health aspects | Atrial fibrillation | Anticoagulants | Stroke | Kidney diseases | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 15, pp. 1790 - 1800
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A508 - A508
Journal Article
European Heart Journal, ISSN 0195-668X, 05/2018, Volume 39, Issue 19, pp. 1698 - 1705a
Abstract Aims We examined the risks of all-cause mortality, stroke, major bleeding, and recurrent traumatic injury associated with resumption of vitamin K... 
Oral anticoagulation | Warfarin | Traumatic injury | Atrial fibrillation | Bleeding | NOAC | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEMORRHAGE | TRENDS | DABIGATRAN | USAGE | FALL | VALIDITY | AGE
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 460 - 460
  Background: Patients with non-valvular atrial fibrillation (NVAF) receiving vitamin K antagonists (VKA) with time in therapeutic range (TTR) <70 % are... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Health aspects | Care and treatment | Atrial fibrillation | Cardiac arrhythmia | Prescription drugs
Journal Article
Journal Article
Thrombosis Research, ISSN 0049-3848, 06/2019, Volume 178, pp. 101 - 109
To investigate the patterns of dose reduction of non-vitamin K antagonist oral anticoagulants (NOAC) in patients with atrial fibrillation (AF). Using Danish... 
Rivaroxaban | Dabigatran | Atrial fibrillation | NOAC | Apixaban | Dose reduction | WARFARIN | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | ANTIPLATELET THERAPY | Transluminal angioplasty | Stroke (Disease) | Hypertension | Care and treatment | Chronic kidney failure | Comorbidity | Analysis | Cardiology
Journal Article
Journal Article